Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Metabolic Syndrome and Related Disorders
|
March 1, 2011
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂
Christos V Rizos, Evangelos N Liberopoulos, Constantinos C Tellis, et al.
Current Vascular Pharmacology
|
July 15, 2010
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis
Asterios Karagiannis, Konstantinos Tziomalos, Panagiotis Anagnostis, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Dry cough as first manifestation of giant-cell arteritis
Asterios Karagiannis, Lemonia Mathiopoulou, Konstantinos Tziomalos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
October 9, 2024
Detection of atrial fibrillation after stroke due to large or small vessel disease: Systematic review and meta-analysis
Matilda Florentin, Dimitrios Sagris, Panagiotis Tasoudis, et al.
Journal of Cardiovascular Development and Disease
|
February 23, 2024
Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study
Petros Spyridonas Adamidis, Matilda Florentin, Evangelos Liberopoulos, et al.
Metabolic Syndrome and Related Disorders
|
November 23, 2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose
Matilda Florentin, Evangelos N Liberopoulos, Christos V Rizos, et al.
Clinical Therapeutics
|
April 20, 2010
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study
Christos V Rizos, Haralampos J Milionis, Michael S Kostapanos, et al.
World Journal of Cardiology
|
July 31, 2025
Structural radial artery modifications following transradial access: Mechanisms, clinical implications, and preventive strategies
Xenofon M Sakellariou, Dimitrios Ν Nikas, Panagiotis Papanagiotou, et al.
European Journal of Internal Medicine
|
March 16, 2011
Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth?
Dimitrios K Christodoulou, Haralampos J Milionis, Panagiota Pappa, et al.
Expert Opinion on Therapeutic Targets
|
January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Metabolic Syndrome and Related Disorders
|
March 1, 2011
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂
Christos V Rizos, Evangelos N Liberopoulos, Constantinos C Tellis, et al.
Current Vascular Pharmacology
|
July 15, 2010
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis
Asterios Karagiannis, Konstantinos Tziomalos, Panagiotis Anagnostis, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Dry cough as first manifestation of giant-cell arteritis
Asterios Karagiannis, Lemonia Mathiopoulou, Konstantinos Tziomalos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
October 9, 2024
Detection of atrial fibrillation after stroke due to large or small vessel disease: Systematic review and meta-analysis
Matilda Florentin, Dimitrios Sagris, Panagiotis Tasoudis, et al.
Journal of Cardiovascular Development and Disease
|
February 23, 2024
Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study
Petros Spyridonas Adamidis, Matilda Florentin, Evangelos Liberopoulos, et al.
Metabolic Syndrome and Related Disorders
|
November 23, 2012
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose
Matilda Florentin, Evangelos N Liberopoulos, Christos V Rizos, et al.
Clinical Therapeutics
|
April 20, 2010
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study
Christos V Rizos, Haralampos J Milionis, Michael S Kostapanos, et al.
World Journal of Cardiology
|
July 31, 2025
Structural radial artery modifications following transradial access: Mechanisms, clinical implications, and preventive strategies
Xenofon M Sakellariou, Dimitrios Ν Nikas, Panagiotis Papanagiotou, et al.
European Journal of Internal Medicine
|
March 16, 2011
Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth?
Dimitrios K Christodoulou, Haralampos J Milionis, Panagiota Pappa, et al.
Expert Opinion on Therapeutic Targets
|
January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Page
of 7